CIK 0000725363 · Non-accelerated filer<br>Smaller reporting company
CEL SCI CORP
Sign in to watch- Ticker
- CVM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Incorporated
- CO
- Entity type
- operating
- EIN
- 840916344
- Phone
- 7035069460
- Business address
- 8229 BOONE BLVD ., SUITE 802, VIENNA, VA, 22182
- Open-market buys, last 90 days
- $138,000
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$138,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-30 | TALOR EYAL Chief Scientific Officer | Grant or award | +1,165 | $2.06 | $2K | 10,483 |
| 2026-09-30 | PRICHEP PATRICIA B Chief Financial Officer | Grant or award | +2,082 | $2.06 | $4K | 19,571 |
| 2026-09-30 | KERSTEN GEERT R Chief Executive Officer | Grant or award | +2,621 | $2.06 | $5K | 318,763 |
| 2026-08-25 | KERSTEN GEERT R Chief Executive Officer | Purchase | +100,000 | $1.38 | $138K | 316,142 |
| 2026-08-14 | BAILLAVOINE BRUNO JEAN-MARIE Director | Grant or award · Options | +110,000 | $0.01 | $1K | 138,021 |
| 2026-08-14 | Watson Robert Eugene Director | Grant or award · Options | +110,000 | $0.01 | $1K | 137,271 |
| 2026-08-14 | CIPRIANO JOHN Senior Vice President | Grant or award · Options | +80,000 | $0.01 | $800 | 118,010 |
| 2026-08-14 | TALOR EYAL Chief Scientific Officer | Grant or award · Options | +250,000 | $0.01 | $3K | 331,625 |
| 2026-08-14 | PRICHEP PATRICIA B Chief Financial Officer | Grant or award · Options | +225,000 | $0.01 | $2K | 299,693 |
| 2026-08-14 | KERSTEN GEERT R Chief Executive Officer | Grant or award · Options | +300,000 | $0.01 | $3K | 452,380 |
| 2026-06-30 | TALOR EYAL Chief Scientific Officer | Grant or award | +2,307 | $1.04 | $2K | 9,318 |
| 2026-06-30 | PRICHEP PATRICIA B Chief Financial Officer | Grant or award | +4,125 | $1.04 | $4K | 17,489 |
| 2026-06-30 | KERSTEN GEERT R Chief Executive Officer | Grant or award | +5,192 | $1.04 | $5K | 216,142 |
| 2026-05-14 | KERSTEN GEERT R Chief Executive Officer | Purchase | +300,000 | $1.20 | $360K | 311,547 |
| 2026-05-13 | KERSTEN GEERT R Chief Executive Officer | Purchase | +100,000 | $1.19 | $119K | 222,497 |
| 2026-03-31 | TALOR EYAL Chief Scientific Officer | Grant or award | +747 | $3.21 | $2K | 7,011 |
| 2026-03-31 | PRICHEP PATRICIA B Chief Financial Officer | Grant or award | +1,336 | $3.21 | $4K | 13,364 |
| 2026-03-31 | KERSTEN GEERT R Chief Executive Officer | Grant or award | +1,682 | $3.21 | $5K | 122,497 |
| 2026-01-22 | KERSTEN GEERT R Chief Executive Officer | Purchase | +38,023 | $5.26 | $200K | 120,815 |
| 2025-12-31 | TALOR EYAL Chief Scientific Officer | Grant or award | +456 | $5.26 | $2K | 6,264 |
Page 1 of 5 · 100 trades